Muung Medica LLC is a medical technology company established on January 24, 2023, and registered by the Minsk District Executive Committee under registration number 692216837.
We develop and implement innovative solutions for emergency and planned medical care, with a focus on bleeding control, wound management, and related clinical needs. Our product portfolio includes highly effective hemostatic agents, atraumatic wound dressings, postoperative care products, and diagnostic software.
Our solutions are intended for use across military, pre-hospital, and hospital settings, supporting healthcare professionals in the management of acute and chronic wounds. We aim to combine practical clinical value, product quality, and cost efficiency to make essential medical solutions more accessible.
Innovation and Product Development
Our approach to innovation is driven by the needs of healthcare professionals and the challenges of modern medical practice. We focus on developing practical, effective, and user-oriented solutions that support clinical workflows and improve the management of bleeding and wounds.
Our development activities encompass material science, formulation development, product design, and the evaluation of medical performance. We continuously explore opportunities to expand our product portfolio and develop solutions for a broader range of clinical applications.
Quality and Scientific Expertise
Product quality and safety are central to our work. We recognize that the performance and reliability of medical products are directly connected to patient care.
Our technologies and products are developed and evaluated by highly qualified specialists in medicine, chemistry, and biology. Our scientific team includes PhD-level experts with experience in technology development, technical evaluation, and preclinical and clinical research.
In collaboration with leading research institutes and clinical centers, we conduct comprehensive sanitary, hygienic, preclinical, clinical, and other evaluations to support product safety and performance.
Our experts are authors of scientific publications and patents, leaders and contributors to research projects, winners and finalists of national innovation competitions, and members of international professional associations.
Clinical Focus and Practical Applications
We develop solutions for a wide range of clinical applications, from emergency bleeding control to wound management and postoperative care.
Our product development is guided by the practical requirements of healthcare professionals, including ease of use, reliable performance, and suitability for different care environments. We seek to develop products that can be integrated into existing medical workflows and support effective patient care.
International Cooperation
Muung Medica regularly participates in specialized international exhibitions and industry events, using these opportunities to exchange expertise, present its developments, and establish professional partnerships.
The company is a member of the Belarusian Chamber of Commerce and Industry and actively collaborates with its relevant divisions to promote its products in international markets.
We are open to cooperation with distributors, medical institutions, research organizations, and industrial partners interested in developing and introducing innovative medical solutions.
Production Development and Investment
Since July 9, 2026, Muung Medica has been a resident of the China-Belarus Industrial Park “Great Stone,” where it is implementing an investment project to establish a modern, high-tech production facility for hemostatic products.
The project is aimed at developing manufacturing capabilities, supporting product localization, and creating a foundation for the further expansion of the company’s product portfolio and international activities.
Localization and Strategic Partnerships
In addition to supplying finished products, we actively cooperate with international partners to localize the production of socially significant medical solutions.
We believe that strategic partnerships can contribute to the development of local manufacturing, strengthen supply chains, and improve access to essential medical products. Our goal is to build long-term cooperation based on shared expertise, quality, and sustainable business development.
Advantages of Cooperation
Innovative product portfolio. Solutions developed to address important needs in bleeding control, wound care, and emergency and planned medical care.
Scientific and clinical expertise. A multidisciplinary team with experience in medical, chemical, and biological research, technology development, and product evaluation.
Quality-focused development. A commitment to product safety, performance, and continuous improvement.
Competitive potential. Solutions designed to offer competitive clinical performance and cost efficiency.
Flexible cooperation. Opportunities for collaboration in distribution, localization, product development, and manufacturing.
International growth potential. A growing network of professional partnerships and a focus on expanding access to medical solutions in international markets.